From January to March 2022, Russia imported 5,200 tons of APIs worth 53 billion RUB (customs clearance and VAT included), up 23.1% in physical terms from Q1 2021. However, the growth rate in monetary terms (rubles) is –7.5%, the first negative growth rate in 10 years.

From January to March 2022, Russia imported 200.6 billion rubles’ worth of ready-made drugs (customs clearance and VAT included), up 11.5% from the same period in 2021 in monetary terms (rubles). The import of bulk drugs rose by 17.4% in rubles. In physical terms, the import of ready-made drugs was the same as one year earlier, 429.4 million packages. As for bulk drugs, the import volume was 414.5 million minimum dosage units (MDU), down 29.3% from last year.

In January–March 2022, Russian manufacturers produced 190.2 billion rubles’ worth of pharmaceutical drugs (manufacturer’s prices, VAT included), up 27% from January–March 2021. In physical terms, the production volume was 1.09 billion packages, up 1.6% from the same period in 2021. If calculated in minimum dosage units (MDU), the growth rate was 2.5%, with 20 billion MDUs produced.

From January to March 2022, the top Russian marketplaces sold RUB 338.7 million worth of veterinary drugs (retail prices, VAT included). Compared to Q1 2021, the sales increased by a factor of 2.6, with the revenue of the first three quarters exceeding that of 2020 and amounting to half of that in 2021. In physical terms, the growth rate was 72%, while the sales volume was 1.8 million minimum dosage units (MDU).